
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 971 | 971 | 1057 | 1356 | 1635 | 2355 |
Fund Return | -2.85% | -2.93% | 5.69% | 10.7% | 10.33% | 8.94% |
Place in category | - | - | - | - | - | - |
% in Category | 92 | 93 | 95 | 92 | 85 | 84 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC Canadian Dividend Fund Series I | 24.54B | 8.01 | 12.92 | 9.56 | ||
RBC Canadian Div Fund Series D CAD | 24.54B | 7.74 | 12.33 | 8.96 | ||
RBC Canadian Div Fund Series F CAD | 24.54B | 7.88 | 12.63 | 9.27 | ||
RBC Sel Gr Port Sr F CAD | 19.28B | 5.03 | 13.10 | 7.72 | ||
RBC Sel Gr Port Sr T5 | 19.28B | 4.51 | 11.97 | 6.63 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PH N US Multi Style All Cap Eq D | 10.44B | -0.61 | 20.69 | 12.39 | ||
PH N US Multi Style All Cap Eq F | 10.44B | -0.49 | 20.98 | 12.66 | ||
RBC Priv US Lg Cap Cr Eq Sr F CAD | 6.09B | -0.24 | 21.08 | 13.12 | ||
DFA US Core Equity Class F CAD | 5.73B | -0.60 | 18.92 | 12.12 | ||
TD U.S. Blue Chip Equity Fund I CAD | 4.78B | -3.44 | 18.16 | 11.54 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
JPMorgan | US46625H1005 | 3.76 | 291.27 | +0.47% | |
Microsoft | US5949181045 | 3.16 | 510.04 | -0.32% | |
Union Pacific | US9078181081 | 3.12 | 224.87 | -1.15% | |
Abbott Labs | US0028241000 | 3.02 | 123.67 | +2.62% | |
Alphabet A | US02079K3059 | 2.95 | 185.04 | +0.80% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Sell |
Summary | Neutral | Strong Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review